BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 17569133)

  • 21. Rectal Indomethacin Reduces Pancreatitis in High- and Low-Risk Patients Undergoing Endoscopic Retrograde Cholangiopancreatography.
    Thiruvengadam NR; Forde KA; Ma GK; Ahmad N; Chandrasekhara V; Ginsberg GG; Ho IK; Jaffe D; Panganamamula KV; Kochman ML
    Gastroenterology; 2016 Aug; 151(2):288-297.e4. PubMed ID: 27215656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting and preventing post-ERCP pancreatitis.
    Baillie J
    Curr Gastroenterol Rep; 2002 Apr; 4(2):112-9. PubMed ID: 11900675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prophylactic rectal indomethacin may be ineffective for preventing post-endoscopic retrograde cholangiopancreatography pancreatitis in general patients: A meta-analysis.
    Feng Y; Navaneethan U; Zhu X; Varadarajulu S; Schwartz I; Hawes R; Hasan M; Yang A
    Dig Endosc; 2017 May; 29(3):272-280. PubMed ID: 27914176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What are the predictors of post-ERCP pancreatitis, and how useful are they?
    Sultan S; Baillie J
    JOP; 2002 Nov; 3(6):188-94. PubMed ID: 12432185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positive correlation between pancreatic volume and post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Maruyama H; Shiba M; Ishikawa-Kakiya Y; Kato K; Ominami M; Fukunaga S; Otani K; Hosomi S; Tanaka F; Kamata N; Taira K; Nagami Y; Yamagami H; Tanigawa T; Watanabe T; Yamamoto A; Kabata D; Shintani A; Fujiwara Y
    J Gastroenterol Hepatol; 2020 May; 35(5):769-776. PubMed ID: 31618801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prophecy about post-endoscopic retrograde cholangiopancreatography pancreatitis: from divination to science.
    Moon SH; Kim MH
    World J Gastroenterol; 2013 Feb; 19(5):631-7. PubMed ID: 23429236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early measures of hemoconcentration and inflammation are predictive of prolonged hospitalization from post- endoscopic retrograde cholangiopancreatography pancreatitis.
    Coté GA; Sagi SV; Schmidt SE; Lehman GA; McHenry L; Fogel E; Watkins J; Sherman S
    Pancreas; 2013 Jul; 42(5):850-4. PubMed ID: 23648842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting post-endoscopic retrograde cholangiopancreatography pancreatitis using the 4-h serum lipase level.
    Papachristos A; Howard T; Thomson BN; Thomas PR
    ANZ J Surg; 2018 Jan; 88(1-2):82-86. PubMed ID: 27457275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: a randomized, double-blind, placebo-controlled trial.
    Katsinelos P; Fasoulas K; Paroutoglou G; Chatzimavroudis G; Beltsis A; Terzoudis S; Katsinelos T; Dimou E; Zavos C; Kaltsa A; Kountouras J
    Endoscopy; 2012 Jan; 44(1):53-9. PubMed ID: 22198776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of the Tokyo trial of prevention of post-ERCP pancreatitis with risperidone-2: a multicenter, randomized, placebo-controlled, double-blind clinical trial.
    Uchino R; Isayama H; Tsujino T; Sasahira N; Ito Y; Matsubara S; Takahara N; Arizumi T; Toda N; Mohri D; Togawa O; Yagioka H; Yanagihara Y; Nakajima K; Akiyama D; Hamada T; Miyabayashi K; Mizuno S; Kawakubo K; Kogure H; Sasaki T; Yamamoto N; Nakai Y; Hirano K; Tada M; Koike K
    Gastrointest Endosc; 2013 Dec; 78(6):842-850. PubMed ID: 23910063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of rectal indomethacin, diclofenac, and naproxen for the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis.
    Mohammad Alizadeh AH; Abbasinazari M; Hatami B; Abdi S; Ahmadpour F; Dabir S; Nematollahi A; Fatehi S; Pourhoseingholi MA
    Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):349-354. PubMed ID: 27849643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Neutrophil-Lymphocyte Ratio as an Early Predictive Marker of the Severity of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.
    Lee SH; Lee TY; Cheon YK
    Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056321
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative study of strategies for preventing post-ERCP pancreatitis after early precut sphincterotomy for biliary access.
    Ang TL; Kwek AB; Song M; Li JW; Thurairajah PH
    J Dig Dis; 2016 Oct; 17(10):692-696. PubMed ID: 27556283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Simple ways of reducing the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis].
    Leerhøy B; Regeur JVH; Elmunzer BJ; Novovic S
    Ugeskr Laeger; 2019 Apr; 181(16):. PubMed ID: 31036154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-6, IL-10 and TNFα do not improve early detection of post-endoscopic retrograde cholangiopancreatography acute pancreatitis: a prospective cohort study.
    Concepción-Martín M; Gómez-Oliva C; Juanes A; Mora J; Vidal S; Díez X; Torras X; Sainz S; Villanueva C; Farré A; Guarner-Argente C; Guarner C
    Sci Rep; 2016 Sep; 6():33492. PubMed ID: 27642079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic use of statins and risk of post-ERCP acute pancreatitis (STARK): Study protocol for an international multicenter prospective cohort study.
    Korpela T; Cárdenas-Jaén K; Archibugi L; Poropat G; Maisonneuve P; Arcidiacono PG; De Pretis N; Löhr M; Capurso G; de-Madaria E
    Dig Liver Dis; 2018 Dec; 50(12):1362-1365. PubMed ID: 30224317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreatic stents for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis should be inserted up to the pancreatic body or tail.
    Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Watanabe K; Nakamura J; Kikuchi H; Waragai Y; Takasumi M; Hikichi T; Ohira H
    World J Gastroenterol; 2018 Jun; 24(22):2392-2399. PubMed ID: 29904246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of greater intravenous volume infusion with shorter hospitalization for patients with post-ERCP pancreatitis.
    Sagi SV; Schmidt S; Fogel E; Lehman GA; McHenry L; Sherman S; Watkins J; Coté GA
    J Gastroenterol Hepatol; 2014 Jun; 29(6):1316-20. PubMed ID: 24372871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protocol-based medical management of post-ERCP pancreatitis.
    Reddy N; Wilcox CM; Tamhane A; Eloubeidi MA; Varadarajulu S
    J Gastroenterol Hepatol; 2008 Mar; 23(3):385-92. PubMed ID: 18318823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meta-analysis of prophylactic allopurinol use in post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Zheng M; Chen Y; Bai J; Xin Y; Pan X; Zhao L
    Pancreas; 2008 Oct; 37(3):247-53. PubMed ID: 18815544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.